OBIO
Price
$4.75
Change
-$0.19 (-3.85%)
Updated
Dec 18, 04:59 PM (EDT)
PGEN
Price
$0.72
Change
+$0.03 (+4.35%)
Updated
Dec 18, 04:59 PM (EDT)
69 days until earnings call
Ad is loading...

OBIO vs PGEN

Header iconOBIO vs PGEN Comparison
Open Charts OBIO vs PGENBanner chart's image
Orchestra BioMed Holdings
Price$4.75
Change-$0.19 (-3.85%)
Volume$13.29K
CapitalizationN/A
Precigen
Price$0.72
Change+$0.03 (+4.35%)
Volume$6.71K
CapitalizationN/A
OBIO vs PGEN Comparison Chart
Loading...
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OBIO vs. PGEN commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OBIO is a Buy and PGEN is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (OBIO: $4.94 vs. PGEN: $0.69)
Brand notoriety: OBIO and PGEN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OBIO: 106% vs. PGEN: 135%
Market capitalization -- OBIO: $179.67M vs. PGEN: $211.45M
OBIO [@Biotechnology] is valued at $179.67M. PGEN’s [@Biotechnology] market capitalization is $211.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OBIO’s FA Score shows that 0 FA rating(s) are green whilePGEN’s FA Score has 0 green FA rating(s).

  • OBIO’s FA Score: 0 green, 5 red.
  • PGEN’s FA Score: 0 green, 5 red.
According to our system of comparison, OBIO is a better buy in the long-term than PGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OBIO’s TA Score shows that 3 TA indicator(s) are bullish while PGEN’s TA Score has 3 bullish TA indicator(s).

  • OBIO’s TA Score: 3 bullish, 6 bearish.
  • PGEN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, PGEN is a better buy in the short-term than OBIO.

Price Growth

OBIO (@Biotechnology) experienced а -12.10% price change this week, while PGEN (@Biotechnology) price change was -11.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.91%, and the average quarterly price growth was -1.42%.

Reported Earning Dates

OBIO is expected to report earnings on Jan 25, 2023.

PGEN is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PGEN($211M) has a higher market cap than OBIO($180M). OBIO YTD gains are higher at: -45.893 vs. PGEN (-48.493).
OBIOPGENOBIO / PGEN
Capitalization180M211M85%
EBITDAN/AN/A-
Gain YTD-45.893-48.49395%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/A6.71M-
FUNDAMENTALS RATINGS
PGEN: Fundamental Ratings
PGEN
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
26

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OBIOPGEN
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
40%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
57%
Bullish Trend 10 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
54%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

OBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, OBIO has been loosely correlated with AURA. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if OBIO jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OBIO
1D Price
Change %
OBIO100%
-2.95%
AURA - OBIO
34%
Loosely correlated
-2.47%
INSM - OBIO
33%
Loosely correlated
+0.63%
PGEN - OBIO
32%
Poorly correlated
+2.46%
TRDA - OBIO
30%
Poorly correlated
+2.44%
BPMC - OBIO
30%
Poorly correlated
+1.14%
More

PGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PGEN has been loosely correlated with CRSP. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if PGEN jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PGEN
1D Price
Change %
PGEN100%
+2.46%
CRSP - PGEN
55%
Loosely correlated
+0.88%
NTLA - PGEN
53%
Loosely correlated
-1.87%
ARWR - PGEN
52%
Loosely correlated
-0.45%
BEAM - PGEN
52%
Loosely correlated
-1.21%
RCKT - PGEN
51%
Loosely correlated
+1.36%
More